Navigation Links
Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
Date:4/6/2011

eing developed for the treatment of Clostridium difficile infection (CDI). The FDA granted the Company's request for six-month Priority Review of Optimer's NDA for DIFICID, and has assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 30, 2011. The Company also filed a MAA with the European Medicines Agency (EMA) for fidaxomicin. Pruvel™ is a prodrug in the fluoroquinolone class of antibiotics being developed as a treatment for infectious diarrhea. Additional information can be found at http://www.optimerpharma.com.  

Forward Looking Statements

Statements included in this press release that are not a description of historical facts are forward-looking statements, including without limitation statements related to the potential regulatory approval and commercialization of DIFICID, the expected timing of the FDA's review of the NDA for DIFICID, future activities conducted under the co-promotion agreement, the potential benefits of the co-promotion agreement, including benefits to the commercial launch of DIFICID, the number of hospitals to which DIFICID will be marketed, and the possibility of capturing a portion of the undiagnosed CDI market, Optimer's plans to build its own sales force, potential payments under the co-promotion agreement, and expected trends in the incidence of CDI. Words such as "believes", "would", "anticipates", "plans", "expects", "may", "intend", "will", and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Optimer or Cubist that any of their respective plans will be achieved. Actual results may differ materially from those set forth in this release due to the implementation and continuation of the co-promotion agreement, each party's performance of its respective obligations under the co-promotion agreement, Optimer's and Cubist's ability
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
2. Trading Halted Today in Optimer Pharmaceuticals Stock
3. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
4. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
5. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
6. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
7. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
8. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
9. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
10. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... ARMONK , N.Y. and HAMBURG, Germany ... today announced it is collaborating with Deutsches Elektronen-Synchrotron ( ... Germany , to speed up management and ... Big Data and Analytics architecture based on ... gigabyte per second of data at peak performance and ...
(Date:8/21/2014)... 2014  ACI Clinical ( www.aciclinical.com ) announces ... Committees. Using this solution, trial sponsors ... standard costs and receive the same expertise that ... services. Leveraging a decade of DMC ... development, statistical programming and meeting facilitation), ACI analyzed ...
(Date:8/21/2014)... 21, 2014 CVS Caremark Corporation (NYSE: ... Yields and consideration payable in connection with its previously announced ... 2014 for (1) any and all of its 6.250% Senior ... up to a maximum amount of its 6.125% Senior Notes ... Notes due 2017 (collectively, the "Maximum Tender Offer Notes" and ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6
(Date:8/21/2014)... of Texas MD Anderson Cancer Center today announced a ... breast screening at a network of community breast care ... late November, MD Anderson will become the exclusive provider ... Hermann,s 10 breast care centers, located in Memorial City, ... time, the network will expand to Memorial Hermann,s locations ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Black mothers are less ... here,s one possible reason why: Hospitals in neighborhoods with ... those in areas with more white residents, a U.S. ... are much less common in medical centers where the ... U.S. Centers for Disease Control and Prevention reported Thursday. ...
(Date:8/21/2014)... By Dennis Thompson ... (HealthDay News) -- A combination of therapy and antidepressants ... depression, a new study reports. Four out of ... two years experienced full recovery when treated with cognitive ... other hand, the combination didn,t work much better than ...
(Date:8/21/2014)... Seattle, WA chiropractors Dr. Lincoln ... Chiropractic and Massage Center have recently welcomed two ... Rina Lang, LMP and Mike Larios, LMP have specialized ... techniques, and have developed their expertise working in a ... important in a clinical environment where massage is used ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 The results ... today in The Journal of the American Medical Association ... invasive cancers and reduces unnecessary recalls. Memorial Healthcare System ... the study. , “This study confirms what we already ... harmful cancers we want to find and, at the ...
Breaking Medicine News(10 mins):Health News:MD Anderson and Memorial Hermann to operate breast screening network across Houston area 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 3Health News:Dr. Mary Hayes: Study Shows 3D Mammography Finds More Invasive Cancers While Reducing Unnecessary Recalls 2
... The More You Know, the More You Care About ... Action for World,s Leaders,to ,Put a Face on the ... 25 years,after HIV was discovered, one-third of the people ... about the global HIV and AIDS epidemic,and one-fourth believe ...
... Peninsula Medical School in the South West of England ... providing out of hours services in primary care are ... discussions and carried out telephone interviews with 27 patients ... general practice cover in the evenings and weekends in ...
... female hormone , THURSDAY, Nov. 29 (HealthDay News) -- ... given with estrogen in hormone replacement therapy -- offers ... , They conducted tests on female mice genetically engineered ... conclusion. , Treatment with estrogen blocked the Alzheimer,s-like symptoms ...
... 29 S3 Matching Technologies,patented TeraMatch(R) has ... (TMHP) innovative technology to automate the verification ... that Medicaid does not,allow payments to non-qualified ... TMHP relied on manual data verification searches ...
... to Create New, Database File Storage System to ... Nov. 29 ONStor Inc., the leading,provider of ... that Consortium Health Plans, Inc., a national consortium ... has chosen the ONStor,Bobcat Series NAS Gateway as ...
... STAAR Surgical,Company (Nasdaq: STAA ), a ... products, today announced that it will,present at the ... on,Tuesday, December 4, 2007 at the Millennium Broadway ... Surgical,s Chief Executive Officer, will,discuss the Company,s business ...
Cached Medicine News:Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 2Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 3Health News:AIDS Ignorance: One-Third of Adults Admit Little or No Knowledge of Pandemic 4Health News:Out-of-hours doctors reluctant to do home visits, say patients 2Health News:Progesterone Won't Shield Women Against Alzheimer's 2Health News:S3 Matching Technologies Aids in Reducing Risk to Texas Medicaid System 2Health News:Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStor's Green Clustered NAS Solution 2Health News:Consortium Health Plans Cuts Down on Power Usage and Cooling in Its Data Center Using ONStor's Green Clustered NAS Solution 3Health News:STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference 2
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... is the same as model ... flat internal baffle across the ... baffle slopes forward, leaving space ... sweep the deck and space ...
... The Benchtop Fume Hood is an ... installations in which a number of fume ... schools, junior colleges and universities. Features include ... polyethylene with rounded inside corners for easy ...
This is the second generation of the famous A/O sliding microtome, manufactured in the United States under the Leica trademark....
Medicine Products: